Andreas Rummelt, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 6,443 shares at $84.96 ($537K) on 2012-02-23, disclosed to the SEC on 2012-02-23.
Open-market sale of $537k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.27 | 2,786 | $226K | 42.2% |
| 2 | $84.96 | 3,657 | $311K | 57.8% |
| Total | $83.36 avg | 6,443 | $537K | 100% |
| Filing → |
| ALXN | SELL | 2012-06-08 | $913K | — | Filing → |
| ALXN | SELL | 2011-10-25 | $622K | — | Filing → |
| ALXN | BUY | 2010-05-12 | $263K | — | Filing → |